2026-10-19T01:05:05Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/111362026-10-18T21:13:14Zopenairedrivercom_ebyu_10000col_ebyu_10001

Corrigendum to “What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?” [Int. Immunopharmacol. 105 (2022) 108542](S1567576923011463)(10.1016/j.intimp.2023.110821)Huyut, Mehmet TahirHuyut, ZübeyirIlkbahar, FatihMertoğlu, Cumaerratumhumantherapydrug therapyThe authors regretted writing the ethical approval number of the article incorrectly. This study was approved by Erzincan Binali Yıldırım University Non-Interventional Clinical Research Ethics Committee (Reference No: 28.05.2021, 13–15) The authors would like to apologize for any inconvenience caused. © 2024 Elsevier B.V.Elsevier B.V.2025Correctionhttps://rdlopen.rawdatalibrary.net/r/ebyu/11136https://doi.org/10.1016/j.intimp.2024.1138141567-5769enInternational Immunopharmacologyinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11136